DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Genpharmasec Ltd (GENPHARMA) share price today?

Genpharmasec Ltd (GENPHARMA) is trading at ₹1.07 on the BSE, up 1.90% on the day. Source: DocStoX.

What is the PE ratio of Genpharmasec Ltd?

Genpharmasec Ltd has a price-to-earnings (PE) ratio of 53.5 in the Services sector.

What is the market capitalisation of Genpharmasec Ltd?

Genpharmasec Ltd has a market capitalisation of approximately ₹58 crore.

Genpharmasec Ltd

GENPHARMA·BSE·Services

₹1.07▲ +0.02 (+1.90%)

Services · Commercial Services & Supplies

A steady, established business

Day₹1.03

₹1.08

52W₹1

₹222%

Open

₹1.05

High

₹1.08

Low

₹1.03

Prev Close

₹1.05

Volume

1.36L

VWAP

₹1.06

Snapshot

Key fundamentals

Market Cap

₹58 Cr

P/E Ratio

53.50Expensive

P/B Ratio

0.88

EPS

₹0.02

Book Value

₹1.20

ROE

1.89%Weak

ROCE

3.00%Weak

Dividend Yield

0.00%

Debt / Equity

0.53Moderate

Face Value

₹1.00

52W High

₹2.20

52W Low

₹0.75

Sector

Services

Industry

Commercial Services & Supplies

Expensive

None moatHigh uncertainty

Fair value estimate

₹1

▼ 6.5%downside

Trading at ₹1 — 7% above our estimate

BearFair valueBull

₹1₹1₹1

/100

Business quality — Watch the fundamentals

Growth 50Profitability 3Efficiency 0Valuation 37

Plain English

Our view

A steady, established business
Weak returns on equity (2%)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

53.5Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

1.9%Weak

Above 15% is considered healthy for Indian equities

ROCE

3.0%Weak

Above 18% means capital is working hard

Debt/Eq

0.53Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹58 Cr

P/B

0.88

EPS

₹0.02

Div Yield

—

What changed

Recent changes

No notable changes to report.

What matters

News impact

Overview

Valuation

Expensive

P/E 53.5×

Growth

Strong

+75% rev CAGR

Profitability

Modest

1.9% ROE

Financial health

Comfortable

D/E 0.53

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹1.44L Cr

Trades172

VWAP₹1.06

Face value₹1.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+75.3%

—

10Y

—

Profit

—

10Y

—

EPS

—

10Y

—

Profile

Pros

Stock is trading at 0.88 times its book value
Company is expected to give good quarter
Debtor days have improved from 111 to 76.3 days.
Company's working capital requirements have reduced from 136 days to 61.1 days

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has low interest coverage ratio.
Promoter holding is low: 30.0%
Company has a low return on equity of 1.56% over last 3 years.
Company might be capitalizing the interest cost
Earnings include an other income of Rs.3.16 Cr.
Promoter holding has decreased over last 3 years: -30.0%

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Ownership was broadly stable versus the previous quarter. The QoQ column shows each group's change versus the prior quarter.

30%

Promoter

Promoters

30.0%0.00

Public

61.8%-0.02

FII / FPI

0.0%0.00

DII

0.0%0.00

Others

8.2%

Total shareholders

1,01,134-1,118 QoQ

Quarterly trend

Ownership over time

Q1 FY27

Promoter29.98%

Public61.84%

Others8.18%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1992, Generic Pharmasec Ltd deals in pharmaceutical activities /services and trades in equity shares[1]